https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-tocilizumab/ 2024-08-01T07:30:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-daraprim/ 2024-08-01T07:33:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-valgancyclovir/ 2024-08-01T07:35:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-doxazosinum-1-mg-2-mg/ 2024-08-01T07:39:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-doxazosinum-4mg/ 2024-08-01T07:43:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-ocena-produktu-leczniczego-daraprim-pirymetamina/ 2024-08-02T07:42:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-daraprim-pyrimethamine/ 2024-08-02T08:02:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-enhertu-trastuzumab-derukstekan/ 2024-08-02T08:42:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-enhertu-trastuzumab-deruxtecan/ 2024-08-02T08:45:31+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-teleradioterapia-stereotaktyczna-zyroskopowa-tsz-z-wykorzystaniem-nowatorskiego-urzadzenia-zap-x/ 2024-08-02T10:10:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-gyroscopic-stereotactic-teleradiotherapy-tsz-using-a-novel-zap-x-device/ 2024-08-02T11:44:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-34-2024-w-dniu-12-08-2024-r/ 2024-08-08T06:54:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-przejrzystosci-nr-33-2024-w-dniu-5-sierpnia-2024-roku/ 2024-08-08T06:56:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-34-2024-on-12-august-2024/ 2024-08-08T07:27:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-33-2024-on-5-august-2024/ 2024-08-08T07:29:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-zolgensma-onasemnogene-abeparvovec/ 2024-08-08T07:34:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-ayvakyt-avapritinib/ 2024-08-08T07:35:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-omvoh-mirikizumab/ 2024-08-08T07:37:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-ultomiris-ravulizumab/ 2024-08-08T07:43:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-kuvan-sapropterin/ 2024-08-08T07:46:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-active-substance-lanreotidum/ 2024-08-08T07:49:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-active-substance-octreotidum/ 2024-08-08T07:51:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-active-substance-sulfasalazinum/ 2024-08-08T07:54:30+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-ayvakyt-avapritinibum/ 2024-08-08T07:55:04+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-zolgensma-onasemnogenum-abeparvovecum/ 2024-08-08T07:55:15+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-omvoh-mirikizumabum/ 2024-08-08T07:55:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-ultomiris-rawulizumab-3/ 2024-08-08T07:55:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-kuvan-sapropterinum/ 2024-08-08T07:55:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-lanreotidum/ 2024-08-08T07:56:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-octreotidum/ 2024-08-08T07:56:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-sulfasalazinum/ 2024-08-08T07:56:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-ayvakyt-awaprytynib/ 2024-08-09T10:29:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-zolgensma-onasemnogen-abeparwowek/ 2024-08-09T10:33:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-omvoh-mirikizumab/ 2024-08-09T10:35:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-ultomiris-rawulizumab-3/ 2024-08-09T10:39:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-ayvakyt-avapritinib/ 2024-08-09T10:48:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-omvoh-mirikizumab/ 2024-08-09T10:53:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-zolgensma-onasemnogene-abeparvovec/ 2024-08-09T10:54:06+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-ultomiris-ravulizumab/ 2024-08-09T10:56:21+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-kuvan-dichlorowodorek-sapropteryny-2/ 2024-08-12T10:10:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-kuvan-sapropterin-dihydrochloride/ 2024-08-12T10:14:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-35-2024-w-dniu-19-08-2024-r/ 2024-08-13T10:04:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-35-2024-on19-august-2024/ 2024-08-13T13:30:18+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-raport-z-oceny-efektywnosci-tli-2/ 2024-08-16T05:56:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-tli-effectiveness-evaluation-report/ 2024-08-16T05:57:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-w-sprawie-zasadnosci-wprowadzenia-zmian-w-programie-lekowym-b-75/ 2024-08-16T08:22:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-34-2024-on-12-august-2024/ 2024-08-16T09:07:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-on-the-appropriateness-of-making-changes-to-the-b-75-drug-program/ 2024-08-16T09:10:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-przejrzystosci-nr-34-2024-w-dnia-12-sierpnia-2024-roku/ 2024-08-16T12:01:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-ppz-przyszlosc-bez-cukrzycy/ 2024-08-21T09:47:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-rehabilitacja-zdrowotna-i-wspieranie-aktywnosci-ruchowej-mieszkancow-gminy-rybno-na-lata-2024-2026/ 2024-08-21T09:50:31+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-rehabilitation-and-promotion-of-physical-activity-of-residents-of-the-municipality-of-rybno-for-2024-2026/ 2024-08-21T09:53:54+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-wiazowna-na-lata-2025-2029/ 2024-08-21T09:56:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-in-the-field-of-medical-rehabilitation-of-the-residents-of-the-municipality-of-wiazowna-for-the-years-2025-2029/ 2024-08-21T10:00:52+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-olsztynek-na-lata-2025-2027/ 2024-08-21T10:02:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-in-the-field-of-medical-rehabilitation-of-residents-of-olsztynek-municipality-for-2025-2027/ 2024-08-21T10:04:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-rehabilitacji-dla-mieszkancow-gminy-gozdnica/ 2024-08-21T10:06:50+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-rehabilitation-program-for-residents-of-gozdnica-municipality/ 2024-08-21T10:09:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-4/ 2024-08-21T10:11:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-in-the-field-of-medical-rehabilitation-of-residents-of-the-municipality-of-kolo-aged-60-and-over-for-the-years-2025-2027/ 2024-08-21T10:12:43+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-qznia-zdrowia-kids-w-zakresie-wczesnego-wykrywania-nadwagi-i-otylosci-wsrod-dzieci-i-mlodziezy-zamieszkujacych-gmine-miasta-torun-na-lata-2024-2028/ 2024-08-21T10:14:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-qznia-zdrowia-kids-in-the-early-detection-of-overweight-and-obesity-among-children-and-adolescents-residing-in-the-municipality-of-torun-for-2024-2028/ 2024-08-21T10:16:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-cytologia-na-podlozu-plynnym/ 2024-08-21T11:01:09+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-brukinsa-zanubrutynib-3/ 2024-08-21T11:03:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-35-2024-on-19-august-2024/ 2024-08-22T08:00:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-cytology-on-liquid-medium/ 2024-08-22T08:03:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-brukinsa-zanubrutinib-2/ 2024-08-22T08:05:50+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-z-posiedzenia-rady-przejrzystosci-nr-35-2024-w-dniu-19-sierpnia-2024-roku/ 2024-08-23T07:25:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-i-wczesnego-wykrywania-nadwagi-i-otylosci-uczniow-uczeszczajacych-do-klas-v-vii-szkol-podstawowych-w-gminie-gieraltowice-na-lata-2024-2025/ 2024-08-27T11:28:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-badan-przesiewowych-w-kierunku-wad-wzroku-wsrod-uczniow-klas-pierwszych-i-piatych-szkol-podstawowych-z-terenu-powiatu-bielskiego-w-roku-szkolnym-2025-2026/ 2024-08-27T11:30:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-regionalny-program-zdrowotny-rehabilitacja-kardiologiczna/ 2024-08-27T11:33:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-brukinsa-zanubrutynib/ 2024-08-27T11:47:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-for-prevention-and-early-detection-of-overweight-and-obesity-of-students-attending-classes-v-vii-of-elementary-schools-in-gieraltowice-municipality-for-2024-2025/ 2024-08-27T11:58:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-of-screening-for-vision-defects-among-students-of-first-and-fifth-grades-of-elementary-schools-from-the-bielsko-district-in-the-school-year-2025-2026/ 2024-08-27T12:03:19+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-regional-health-program-cardiac-rehabilitation/ 2024-08-27T12:05:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-brukinsa-zanubrutinib/ 2024-08-27T12:07:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-acquiring-oait-data-for-2023/ 2024-08-28T14:25:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-cytologia-na-podlozu-plynnym/ 2024-08-29T12:47:12+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-cytology-on-liquid-medium/ 2024-08-29T12:50:02+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-kinpeygo-budezonid/ 2024-08-29T13:14:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-kinpeygo-budesonide/ 2024-08-29T13:18:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-kinpeygo-budesonidum/ 2024-08-30T05:23:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-cetuksymab-b-52/ 2024-08-30T05:27:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-cetuksymab-b-4/ 2024-08-30T05:31:38+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-panitumumab/ 2024-08-30T05:34:43+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-temsyrolimus/ 2024-08-30T05:36:50+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-aksytynib-2/ 2024-08-30T05:40:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-trabektedyna/ 2024-08-30T05:42:42+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-rozszerzenie-katalogu-chemioterapii-w-zalaczniku-c-22/ 2024-08-30T05:45:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-enoxaparinum-natricum-nadroparinum-calcicum/ 2024-08-30T05:49:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-36-2024-on-26-august-2024/ 2024-08-30T13:02:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-kinpeygo-budesonide/ 2024-08-30T13:12:41+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-cetuximab-b-52/ 2024-08-30T13:16:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-cetuximab-b-4/ 2024-08-30T13:18:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-panitumumab/ 2024-08-30T13:23:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-temsilrolimus/ 2024-08-30T13:25:28+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-axitinib/ 2024-08-30T13:27:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-trabektedine/ 2024-08-30T13:29:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-expansion-of-the-chemotherapy-catalog-in-appendix-c-22/ 2024-08-30T13:31:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-enoxaparinum-natricum-and-nadroparinum-calcicum/ 2024-08-30T13:33:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-ferriprox-deferipronum/ 2024-09-06T13:19:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-veoza-fezolinetantum/ 2024-09-06T13:20:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-milupa-basic-f-2/ 2024-09-06T13:22:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-phenoxymethylpenicillinum/ 2024-09-06T13:25:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-azathioprinum-2/ 2024-09-06T13:26:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-theophyllinum/ 2024-09-06T13:27:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-ciclosporinum/ 2024-09-06T13:29:23+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-ferriprox-deferiprone/ 2024-09-09T07:19:53+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-veoza-fezolinetant/ 2024-09-09T07:23:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-milupa-basic-f/ 2024-09-09T07:25:08+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-phenoxymethylpenicillinum/ 2024-09-09T07:27:31+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-azathioprinum-2/ 2024-09-09T07:29:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-theophyllinum/ 2024-09-09T07:49:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-ciclosporinum/ 2024-09-09T07:52:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-37-2024-2024-on-2-september-2024/ 2024-09-09T07:54:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-pozyskanie-danych-z-oait-za-2023-rok/ 2024-09-09T10:24:38+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-wczesnego-wykrywania-wad-wzroku-i-zeza-u-dzieci-w-wieku-5-6-lat/ 2024-09-11T09:26:02+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-i-wczesne-wykrywanie-nowotworow-gruczolu-krokowego-wsrod-mieszkancow-gminy-polkowice/ 2024-09-11T09:28:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-and-early-detection-of-prostate-cancer-among-the-residents-of-the-municipality-of-polkowice/ 2024-09-11T09:33:08+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president/ 2024-09-11T09:33:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-ferriprox-deferypron/ 2024-09-11T10:25:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-ferriprox-deferiprone/ 2024-09-11T10:28:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-veoza-fezolinetant/ 2024-09-11T12:36:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-veoza-fezolinetant/ 2024-09-11T12:40:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-z-posiedzenia-rady-przejrzystosci-nr-37-2024-w-dniu-2-wrzesnia-2024-roku/ 2024-09-11T12:42:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-z-posiedzenia-rady-przejrzystosci-nr-36-2024-w-dniu-26-sierpnia-2024-roku/ 2024-09-11T12:45:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-calquence-acalabrutinibum/ 2024-09-12T05:12:14+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-livtencity-maribavirum/ 2024-09-12T05:18:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-oznaczanie-stezenia-wapnia-calkowitego-w-surowicy-krwi-icd9077/ 2024-09-12T05:27:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-z-posiedzenia-rady-przejrzystosci-nr-38-2024-w-dniu-9-wrzesnia-2024-roku/ 2024-09-12T08:52:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-39-2024-w-dniu-16-09-2024-r/ 2024-09-12T08:53:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-39-2024-on-16-september-2024/ 2024-09-16T06:52:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-calquence-acalabrutinib/ 2024-09-16T06:54:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-livtencity-maribavir/ 2024-09-16T06:56:23+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-38-2024-on-9-september-2024/ 2024-09-16T06:57:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-determination-of-serum-total-calcium-concentration-icd-9-o77/ 2024-09-16T06:59:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-milupa-basic-f-2/ 2024-09-17T06:39:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-livtencity-maribawir/ 2024-09-17T06:41:11+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-milupa-basic-f/ 2024-09-17T06:50:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-livtencity-maribavir/ 2024-09-17T06:52:54+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-40-2024-w-dniu-23-09-2024-r/ 2024-09-18T10:35:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-39-2024-w-dniu-16-wrzesnia-2024-roku/ 2024-09-19T04:20:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-takhzyro-lanadelumab/ 2024-09-19T04:38:58+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-adderall-xr-amphetamine-dextroamphetamine/ 2024-09-19T04:42:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-colecalciferolum-2/ 2024-09-19T04:44:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-40-2024-on-23-september-2024/ 2024-09-19T13:04:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-39-2024-on-16-september-2024/ 2024-09-19T13:06:47+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-takhzyro-lanadelumab/ 2024-09-19T13:10:08+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-adderall-xr-amphetamine-dextroamphetamine/ 2024-09-19T13:12:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-colecalciferolum/ 2024-09-19T13:16:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-41-2024-w-dniu-30-09-2024-r/ 2024-09-20T10:11:50+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-41-2024-on-30-september-2024/ 2024-09-20T12:55:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-calquence-akalabrutynib-2/ 2024-09-23T12:15:36+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-oznaczanie-stezenia-wapnia-calkowitego-w-surowicy-krwi-icd-9-o77/ 2024-09-23T12:18:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-calquence-acalabrutinib/ 2024-09-23T12:22:19+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-determination-of-total-serum-calcium-concentration-icd-9-o77/ 2024-09-23T12:24:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-wczesnego-wykrywania-wad-wzroku-i-zeza-u-dzieci-w-wieku-5-6-lat-2/ 2024-09-24T08:48:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-i-wczesne-wykrywanie-nowotworow-gruczolu-krokowego-wsrod-mieszkancow-gminy-polkowice-2/ 2024-09-24T08:50:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-of-early-detection-of-eye-defects-and-strabismus-in-children-aged-5-6-years-old/ 2024-09-24T09:13:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-and-early-detection-of-prostate-cancer-among-the-residents-of-the-municipality-of-polkowice-2/ 2024-09-24T09:15:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-w-zakresie-ppz-48aa-profilaktyka-grypy-sezonowej/ 2024-09-24T09:23:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-12-2024-w-dniu-26-09-2024-r/ 2024-09-25T05:49:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-zasadnosc-wydawania-zgody-na-refundacje-produktu-adderall-xr-amphetamine-dextroamphetamine/ 2024-09-25T06:35:39+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-12-2024-on-26-september-2024/ 2024-09-25T08:48:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-adderall-xr-amphetamine-dextroamphetamine/ 2024-09-25T08:51:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-41-2024-on-30-september-2024-2/ 2024-09-25T08:56:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-polpasca-i-neuralgii-popolpascowej-poprzez-szczepienie-mieszkancow-poznania-w-wieku-co-najmniej-18-lat-z-czynnikami-ryzyka-oraz-50-lat-i-starszych-na-lata-2025-2027/ 2024-09-25T14:00:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-polpasca-i-neuralgii-popolpascowej-poprzez-szczepienie-mieszkancow-poznania-w-wieku-65-lat-i-starszych-o-zwiekszonym-ryzyku-zachorowania-na-polpasiec-na-lata-2025-2027/ 2024-09-25T14:02:03+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-zakazen-rsv-obejmujacy-szczepienia-osob-w-wieku-60-lat-i-starszych-z-grup-ryzyka-zamieszkalych-w-poznaniu-na-lata-2025-2027/ 2024-09-25T14:03:28+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-of-herpes-zoster-and-postherpetic-neuralgia-by-vaccination-of-poznan-residents-aged-at-least-18-years-with-risk-factors-and-50-years-and-older-for-the-years-2025/ 2024-09-25T14:11:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-of-herpes-zoster-and-postherpetic-neuralgia-by-vaccination-of-poznan-residents-aged-65-and-older-with-an-increased-risk-of-developing-herpes-zoster-for-the-years/ 2024-09-25T14:13:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-rsv-infection-prevention-program-including-vaccination-of-people-aged-60-and-older-from-risk-groups-residing-in-poznan-for-the-years-2025-2027/ 2024-09-25T14:15:38+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-k-yo/ 2024-09-26T12:26:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-disulone-dapsonum-2/ 2024-09-26T12:31:53+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-40-2024-w-dniu-23-wrzesnia-2024-roku/ 2024-09-26T12:43:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-k-yo/ 2024-09-27T12:10:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-disulone-dapsoneum/ 2024-09-27T12:13:26+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-calcort-deflazacort/ 2024-09-27T12:15:14+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-40-2024-on-23-september-2024/ 2024-09-27T12:16:36+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-13-2024-w-dniu-3-10-2024-r/ 2024-09-30T12:30:49+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-42-2024-w-dniu-7-10-2024-r/ 2024-09-30T12:32:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-26-wrzesnia-2024-r/ 2024-10-01T08:15:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-42-2024-on-7-october-2024/ 2024-10-01T13:29:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-42-2024-on-7-october-2024/ 2024-10-01T13:30:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-40-2024-w-dniu-23-wrzesnia-2024-roku-2/ 2024-10-02T12:37:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-imfinzi-durwalumab/ 2024-10-02T13:15:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-enspryng-satralizumabum/ 2024-10-02T13:17:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-wyciecie-ogniska-gruczolistosci-srodmacicznej-z-zatoki-douglasa/ 2024-10-02T13:23:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-wyciecie-lub-zniszczenie-zmiany-w-zatoce-douglasa-inne/ 2024-10-03T09:07:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-srodek-spozywczy-specjalnego-przeznaczenia-zywieniowego-k-yo/ 2024-10-04T06:56:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-takhzyro-lanadelumab/ 2024-10-04T06:59:58+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-wyciecie-ogniska-gruczolistosci-srodmacicznej-z-zatoki-douglasa/ 2024-10-04T07:02:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-wyciecie-lub-zniszczenie-zmiany-w-zatoce-douglasa-inne/ 2024-10-04T07:04:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-imfinzi-durwalumab-imjudo-tremelimumab/ 2024-10-04T07:06:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-imjudo-tremelimumab-imfinzi-durwalumab/ 2024-10-04T07:08:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-zaburzen-depresyjnych-wsrod-nastolatkow-uczeszczajacych-do-szkol-na-terenie-gminy-miasta-marki-na-lata-2025-2027/ 2024-10-04T07:10:44+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-profilaktyki-i-wczesnego-wykrywania-nadwagi-i-otylosci-wsrod-uczniow-klas-i-iii-szkol-podstawowych-z-terenu-wojewodztwa-warminsko-mazurskiego/ 2024-10-04T07:17:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-msciwojow-w-2024-roku/ 2024-10-04T07:18:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-enspryng-satralizumab/ 2024-10-04T07:48:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-from-the-tariff-council-on-26-september-2024/ 2024-10-07T08:40:50+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-41-2024-30-september-2024/ 2024-10-07T08:43:48+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-excision-of-a-focus-of-intramural-adenomyosis-from-the-sinus-of-douglas/ 2024-10-07T08:46:36+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-excision-or-destruction-of-a-lesion-in-the-sinus-of-douglas-other/ 2024-10-07T08:49:53+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-enspryng-satralizumab/ 2024-10-07T08:51:30+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-imjudo-tremelimumab/ 2024-10-07T08:52:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-imjudo-tremelimumab/ 2024-10-07T08:53:46+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-imfinzi-durvalumab/ 2024-10-07T08:55:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-k-yo/ 2024-10-07T08:58:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-takhzyro-lanadelumab/ 2024-10-07T09:00:45+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-excision-of-a-focus-of-intramural-adenomyosis-from-the-sinus-of-douglas/ 2024-10-07T09:02:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-excision-or-destruction-of-a-lesion-in-the-sinus-of-douglas-other/ 2024-10-07T09:06:32+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-imfinzi-durvalumab-imjudo-tremelimumab/ 2024-10-07T09:09:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-imjudo-tremelimumab-imfinzi-durvalumab/ 2024-10-07T09:11:55+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-the-prevention-and-early-detection-of-overweight-and-obesity-among-students-in-grades-i-iii-of-elementary-schools-from-the-warmian-masurian-voivode/ 2024-10-07T09:15:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-for-the-prevention-of-depressive-disorders-among-adolescents-attending-schools-in-the-municipality-of-the-city-of-marki-for-2025-2027/ 2024-10-07T09:16:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-prevention-program-in-the-field-of-medical-rehabilitation-of-the-residents-of-the-msciwojow-municipality-in-2024/ 2024-10-07T09:18:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-enspryng-satralizumab/ 2024-10-07T09:20:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/wytyczne-do-programow-pilotazowych-na-podstawie-doswiadczen-z-dotychczas-ocenianych-programow-oraz-dokumentu-opracowanego-przez-aotmit-wytyczne-do-programow-pilotazowych-przygotow/ 2024-10-07T11:53:14+00:00 https://www.aotm.gov.pl/wp-content/uploads/2024/10/AOTM_pilotaz-szkolenie-8-pazdziernika-v5-FV.jpg https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-colcort-deflazakort/ 2024-10-09T07:00:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-42-2024-w-dniu-7-pazdziernika-2024-roku/ 2024-10-09T10:43:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/pazdziernik-miesiac-swiadomosci-raka-piersi/ 2024-10-09T11:05:55+00:00 https://www.aotm.gov.pl/wp-content/uploads/2024/10/Slajd1.jpg https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-42-2024-on-7-october/ 2024-10-10T11:40:41+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-mct-oil/ 2024-10-10T11:42:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/tanowisko-rady-przejrzystosci-mct-oil/ 2024-10-10T11:43:08+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-43-2023-on-14-october-2024/ 2024-10-10T13:31:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/spotkanie-krajowych-organow-wlasciwych-ds-ustalania-cen-i-refundacji-oraz-platnikow-publicznej-opieki-zdrowotnej-ncapr/ 2024-10-10T14:19:58+00:00 https://www.aotm.gov.pl/wp-content/uploads/2024/10/obraz-scaled.jpg https://www.aotm.gov.pl/en/aktualnosci/najnowsze/meeting-of-the-national-competent-authorities-on-pricing-and-reimbursement-and-public-healthcare-payers-ncapr/ 2024-10-10T14:20:57+00:00 https://www.aotm.gov.pl/wp-content/uploads/2024/10/obraz-scaled.jpg https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-mct-oil-2/ 2024-10-11T11:28:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-mct-oil/ 2024-10-11T11:30:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/dzien-edukacji-narodowej/ 2024-10-14T09:31:04+00:00 https://www.aotm.gov.pl/wp-content/uploads/2024/10/Dzien-edukacji-2024-v6.png https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-szczepien-profilaktycznych-przeciwko-meningokokom-w-gminie-maslow-na-lata-2025-2029/ 2024-10-14T12:55:50+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-wsparcia-diagnostyki-i-leczenia-nieplodnosci-na-terenie-wojewodztwa-dolnoslaskiego/ 2024-10-14T12:57:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-wczesnego-wykrywania-nadwagi-otylosci-i-cukrzycy-typu-2-wsrod-pelnoletnich-aktywnych-zawodowo-mieszkancow-gminy-miasta-torun-pn-qznia-zdrowia/ 2024-10-14T12:58:31+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-preventive-vaccination-program-against-meningococcus-in-the-municipality-of-maslow-for-2025-2029/ 2024-10-14T13:01:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-in-support-of-diagnosis-and-treatment-of-infertility-in-the-lower-silesian-province/ 2024-10-14T13:02:55+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-early-detection-of-overweight-obesity-and-type-2-diabetes-among-economically-active-adult-residents-of-the-municipality-of-the-city-of-torun-title/ 2024-10-14T13:04:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-43-2024-w-dniu-14-10-2024-r/ 2024-10-15T06:25:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-44-2024-w-dniu-21-10-2024-r/ 2024-10-15T08:03:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-w-zakresie-ppz-48aa-profilaktyka-zakazen-wirusem-brodawczaka-ludzkiego-hpv/ 2024-10-16T11:59:02+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-43-2024-w-dniu-14-pazdziernika-2024-roku/ 2024-10-17T09:51:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-propafenonum/ 2024-10-17T10:12:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-metoprololum/ 2024-10-17T10:19:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-oznaczanie-alfa-fetoproteiny-w-ramach-nieinwazyjnej-diagnostyki-prenatalnej/ 2024-10-17T10:36:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-oznaczanie-lozyskowego-czynnika-wzrostu-placental-growth-factorplgf/ 2024-10-17T10:37:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-badanie-wolnego-dna-plodowego-cffdna/ 2024-10-17T10:38:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-oznaczanie-estriolu-w-ramach-nieinwazyjnej-diagnostyki-prenatalnej/ 2024-10-18T08:11:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-jemperli-dostarlimabum-2/ 2024-10-18T08:12:00+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-citrulline-200-citrulline-1000-oraz-l-citrulline/ 2024-10-18T08:12:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-45-2024-w-dniu-28-10-2024-r/ 2024-10-21T05:50:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-44-2024-on-21-october-2024/ 2024-10-21T10:47:57+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-43-2024-on-14-october-2024/ 2024-10-21T10:49:14+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-free-fetal-dna-cffdna-testing/ 2024-10-21T10:51:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-placental-growth-factor-plgf-determination/ 2024-10-21T11:02:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-determination-of-alpha-fetoprotein-as-part-of-non-invasive-prenatal-diagnosis/ 2024-10-21T11:08:50+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-determination-of-estriol-as-part-of-non-invasive-prenatal-diagnosis/ 2024-10-21T11:27:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-jemperli-dostarlimab/ 2024-10-21T11:29:26+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-citrulline-200-citrulline-1000-l-citrulline/ 2024-10-21T11:31:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-propafenonum/ 2024-10-21T11:34:05+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-mycophenolas-mofetil/ 2024-10-21T11:35:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-metoprololum/ 2024-10-21T11:36:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-45-2024-on-28-ocotober-2024/ 2024-10-21T11:38:18+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-oznaczanie-alfa-fetoproteiny/ 2024-10-22T12:30:53+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-the-determination-of-alpha-fetoprotein/ 2024-10-22T12:32:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-oznaczanie-estriolu/ 2024-10-22T12:35:00+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-determination-of-estriol/ 2024-10-22T12:36:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-mycophenolas-mofetil-2/ 2024-10-22T12:49:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-44-2024-w-dniu-21-pazdziernika-2024-roku/ 2024-10-24T04:36:52+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-opdivo-niwolumab-5/ 2024-10-24T04:40:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-elvanse/ 2024-10-24T04:42:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-w-sprawie-zasadnosci-wprowadzenia-zmian-w-programie-lekowym-b-111/ 2024-10-24T05:00:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-44-2024-on-21-october-2024/ 2024-10-24T09:56:57+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-opdivo-nivolumab-3/ 2024-10-24T09:58:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-elvanse/ 2024-10-24T10:00:23+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-on-the-appropriateness-of-making-changes-to-the-b-111-drug-program/ 2024-10-24T10:03:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-3-pazdziernika-2024-r/ 2024-10-25T10:08:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-oznaczanie-lozyskowego-czynnika-wzrostu-plgf-w-nieinwazyjnej-diagnostyce-prenatalne/ 2024-10-25T11:01:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-46-2024-w-dniu-04-11-2024-r/ 2024-10-25T11:01:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-disulone-dapsonum/ 2024-10-25T11:04:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-badanie-wolnego-dna-plodowego-cffdna/ 2024-10-25T11:07:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-determination-of-placental-growth-factor-plgf-in-non-invasive-prenatal-diagnosis/ 2024-10-28T12:19:53+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-46-2024-on-4-november-2024/ 2024-10-28T12:21:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-disulone-dapsoneum/ 2024-10-28T12:23:36+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-free-fetal-dna-cffdna-testing-for-non-invasive-prenatal-diagnosis/ 2024-10-28T12:25:38+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-14-2024-w-dniu-31-10-2024-r/ 2024-10-29T17:00:15+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-cukrzycy-typu-2-oraz-chorob-ukladu-sercowo-naczyniowego-dla-mieszkancow-gminy-polczyn-zdroj-na-lata-2025-2029/ 2024-10-30T14:45:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-projekt-programu-poprawy-opieki-nad-matka-i-dzieckiem-w-wojewodztwie-opolskim-w-latach-2024-2026/ 2024-10-30T14:46:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-kompleksowej-terapii-i-rehabilitacji-osob-w-wieku-0-25-lat-z-terenu-miasta-zabrze-2/ 2024-10-30T14:48:11+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-lonsurf-trifluridinum-tipiracilum/ 2024-10-31T05:43:14+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-trodelvy-sacituzumabum-govitecanum/ 2024-10-31T05:52:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-nucala-mepolizumabum/ 2024-10-31T05:57:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-kalydeco-ivacaftorum/ 2024-10-31T06:02:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-program-badan-przesiewowych-noworodkow-w-rzeczpospolitej-polskiej-na-lata-2019-2026/ 2024-10-31T06:15:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-45-2024-w-dniu-28-pazdziernika-2024-roku/ 2024-10-31T06:19:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-niwolumab/ 2024-10-31T06:28:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-kaftrio-ivacaftorum-tezacaftorum-elexacaftorum/ 2024-10-31T07:20:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-14-2024-w-dniu-31-10-2024-r-aktualizacja/ 2024-10-31T10:18:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-for-prevention-of-type-2-diabetes-and-cardiovascular-diseases-for-residents-of-the-municipality-of-polczyn-zdroj-for-2025-2029/ 2024-10-31T12:05:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-draft-program-to-improve-maternal-and-child-care-in-the-opolskie-voivodeship-from-2024-to-2026/ 2024-10-31T12:07:57+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-of-comprehensive-therapy-and-rehabilitation-of-persons-aged-0-25-from-the-city-of-zabrze/ 2024-10-31T12:10:26+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-lonsurf-trifluridine-tipiracil/ 2024-10-31T12:22:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-trodelvy-sacituzumab-govitecan/ 2024-10-31T13:29:00+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-nucala-mepolizumab/ 2024-10-31T13:33:50+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-kalydeco-ivacaftor/ 2024-10-31T13:37:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-kaftrio-ivacaftor-tezacaftor-elexacaftor/ 2024-10-31T13:39:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-program-of-newborn-screening-in-the-republic-of-poland-for-2019-2026/ 2024-10-31T13:41:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-45-2024-on-28-october-2024/ 2024-10-31T13:42:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-nivolumab/ 2024-10-31T13:44:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-14-2024-on-31-october-2024/ 2024-10-31T13:45:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-14-2024-on-31-october-2024-update/ 2024-10-31T13:47:43+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-prezesa-aotmit-w-sprawie-obowiazujacej-wysokosci-progu-kosztu-uzyskania-dodatkowego-roku-zycia-skorygowanego-o-jakosc/ 2024-11-04T07:31:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/warsztat-dla-organizacji-pacjentow-pt-aotmit-w-pigulce-jaka-wartosc-w-ocenie-technologii-medycznych-wnosza-doswiadczenia-organizacji-pacjentow/ 2024-11-04T09:42:47+00:00 https://www.aotm.gov.pl/wp-content/uploads/2024/09/AOTM_PRO_SoM_warsztaty-gotowe-QR-v2.jpg https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-citrulline-200-citrulline-1000-l-citrulline/ 2024-11-04T09:44:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-citrulline-200-citrulline-1000-l-citrulline/ 2024-11-04T09:47:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-wczesnej-diagnostyki-zaburzen-neurorozwojowych-w-populacji-dzieci-w-wieku-0-7-lat-w-pieczy-zastepczej-w-wojewodztwie-lubuskim/ 2024-11-04T09:53:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-early-diagnosis-of-neurodevelopmental-disorders-in-the-population-of-children-aged-0-7-years-in-foster-care-in-lubuskie-province/ 2024-11-04T09:55:11+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-cukrzycy-typu-2-dla-mieszkancow-powiatu-pajeczanskiego-w-wieku-45-64-lat-na-lata-2025-2028/ 2024-11-04T09:56:55+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-type-2-diabetes-prevention-program-for-residents-of-pajeczan-county-aged-45-64-years-for-2025-2028/ 2024-11-04T09:58:44+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktycznych-szczepien-przeciw-meningokokom-typu-b-dzieci-z-gminy-tarnowo-podgorne/ 2024-11-04T10:02:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-of-preventive-vaccination-against-meningococcus-type-b-of-children-from-the-municipality-of-tarnowo-podgorne/ 2024-11-04T10:04:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-badan-przesiewowych-noworodkow-w-rzeczpospolitej-polskiej-na-lata-2019-2026/ 2024-11-04T10:06:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-of-newborn-screening-in-the-republic-of-poland-for-2019-2026/ 2024-11-04T10:08:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-31-pazdziernika-2024-r/ 2024-11-06T11:14:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-47-2024-w-dniu-12-11-2024-r/ 2024-11-06T12:42:15+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-trulicity-dulaglutyd/ 2024-11-07T06:24:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-profilaktyczna-mastektomia/ 2024-11-07T08:55:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-47-2024-on-12-november-2024/ 2024-11-07T13:54:55+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-trulicity-dulaglutide/ 2024-11-07T13:57:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-prophylactic-mastectomy/ 2024-11-07T13:58:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-lonsurf-trifluridinum-tipiracilum/ 2024-11-08T10:24:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-lonsurf-trifluridine-tipiracil/ 2024-11-08T10:26:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-opdivo-niwolumab-6/ 2024-11-08T10:32:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-opdivo-nivolumab-2/ 2024-11-08T10:33:43+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-kaftrio-iwakaftor-tezakaftor-eleksakaftor/ 2024-11-08T10:36:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-kaftrio-ivacaftor-tezacaftor-elexacaftor/ 2024-11-08T10:40:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-kalydeco-iwakaftor/ 2024-11-08T10:42:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-kalydeco-ivacaftor/ 2024-11-08T10:56:49+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-nucala-mepolizumab-2/ 2024-11-08T10:59:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-nucala-mepolizumab-2/ 2024-11-08T11:05:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-jemperli-dostarlimab/ 2024-11-08T11:34:23+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-jemperli-dostarlimab/ 2024-11-08T11:36:14+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-trodelvy-sacytuzumab-gowitekanu/ 2024-11-08T12:57:05+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-trodelvy-sacituzumab-govitecan/ 2024-11-08T13:00:49+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-pozyskanie-danych-z-dzialalnosci-leczniczej-podmiotow-4/ 2024-11-13T15:47:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-48-2024-w-dniu-18-11-2024-r/ 2024-11-14T11:03:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-48-2024-on-18-november-2024/ 2024-11-15T08:14:53+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-abrysvo/ 2024-11-15T13:46:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-trulicity-dulaglutyd-2/ 2024-11-15T13:46:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-abrysvo-2/ 2024-11-15T13:50:50+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-49-2024-w-dniu-25-11-2024-r/ 2024-11-18T13:45:42+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-47-2024-w-dniu-12-listopada-2024-roku/ 2024-11-19T11:58:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-amvuttra-wutrisyran/ 2024-11-19T13:36:55+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-amvuttra-vutrisiran/ 2024-11-19T13:38:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-abrysvo-respiratory-syncytial-virus-vaccine-bivalent-recombinant/ 2024-11-19T13:41:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-trulicity-dulaglutide-2/ 2024-11-19T13:44:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-abrysvo-respiratory-syncytial-virus-vaccine-bivalent-recombinant-2/ 2024-11-19T13:46:18+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-fruitivits/ 2024-11-19T13:46:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-fruitivits/ 2024-11-19T13:48:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-49-2024-on-25-november-2024/ 2024-11-19T13:49:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-47-2024-on-12-november-2024/ 2024-11-19T13:51:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-hipercholesterolemia/ 2024-11-21T09:39:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-shingrix/ 2024-11-21T09:59:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-elrexfio-elranatamab/ 2024-11-21T10:12:04+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-meksyletyna/ 2024-11-21T10:16:15+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-filsuvez-ekstrakt-kory-brzozowej/ 2024-11-21T10:21:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-voxzogo-wosorytyd/ 2024-11-21T10:24:38+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-48-2024-w-dniu-18-listopada-2024-roku/ 2024-11-21T10:28:02+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-luxturna/ 2024-11-21T10:33:54+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-amvuttra-wutrisyran/ 2024-11-22T12:32:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-amvuttra-vutrisiran/ 2024-11-22T12:35:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-abrysvo-szczepionka-przeciw-syncytialnemu-wirusowi-oddechowemu-rsv/ 2024-11-22T12:39:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-abrysvo-respiratory-syncytial-virus-vaccine-bivalent-recombinant/ 2024-11-22T12:41:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-abrysvo-szczepionka-przeciw-syncytialnemu-wirusowi-oddechowemu-rsv-biwalentna-rekombinowana/ 2024-11-22T13:07:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-abrysvo-respiratory-syncytial-virus-vaccine-bivalent-recombinant-2/ 2024-11-22T13:12:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-hypercholesterolemia/ 2024-11-25T09:11:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-luxturna-voretigene-neparvovec/ 2024-11-25T09:16:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-shingrix/ 2024-11-25T09:19:53+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-mexiletine/ 2024-11-25T09:21:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-elrexfio-elranatamab/ 2024-11-25T09:24:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-filsuvez-birch-bark-extract/ 2024-11-25T09:29:39+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-voxzogo-vosoritide/ 2024-11-25T09:32:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-48-2024-on-18-november-2024/ 2024-11-25T09:33:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-50-2024-w-dniu-02-12-2024-r/ 2024-11-26T14:13:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-meksyletyna/ 2024-11-28T08:06:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-mexiletine/ 2024-11-28T08:13:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-50-2024-on-2-december-2024/ 2024-11-28T08:15:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-15-2024-w-dniu-28-11-2024-r/ 2024-11-28T09:02:42+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-wsparcia-osob-po-65-roku-zycia-w-ograniczeniu-wystepowania-zaburzen-procesow-poznawczych-prowadzacych-do-powstawania-chorob-neurodegeneracyjnych/ 2024-11-28T09:20:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-kostomloty-na-lata-2025-2029/ 2024-11-28T09:22:14+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-zaburzen-depresyjnych-dla-dzieci-i-mlodziezy-w-wieku-10-19-lat-na-terenie-miasta-krosna-na-lata-2027-2028/ 2024-11-28T09:24:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-dotyczacy-profilaktyki-nadwagi-i-otylosci-oraz-wad-postawy-wsrod-dzieci-klas-iii-szkol-podstawowych-w-miescie-elk-na-lata-2024-2028/ 2024-11-28T09:25:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-inkontynencji-wsrod-mieszkanek-poznania-w-wieku-30-na-lata-2025-2027/ 2024-11-28T09:26:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-28-listopada-2024-r/ 2024-11-29T09:46:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-talvey-talquetamabum/ 2024-11-29T14:18:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-libtayo-cemiplimabum-2/ 2024-11-29T14:25:19+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-libtayo-cemiplimabum-3/ 2024-11-29T14:28:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-3/ 2024-11-29T14:32:09+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-xmtvi-maxamum-oraz-xmtvi-maxamaid/ 2024-11-29T14:36:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-trandate-labetalol-2/ 2024-11-29T14:40:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-49-2024-w-dniu-25-listopada-2024-roku/ 2024-11-29T14:48:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-8/ 2024-12-02T09:45:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-pomalidomidum/ 2024-12-02T09:53:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-to-support-people-over-65-in-reducing-the-incidence-of-cognitive-impairment-leading-to-neurodegenerative-diseases/ 2024-12-02T10:16:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-medical-rehabilitation-of-residents-of-the-municipality-of-kostomloty-for-2025-2029/ 2024-12-02T11:04:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-the-prevention-of-overweight-and-obesity-and-postural-defects-among-children-in-the-third-grade-of-elementary-school-in-the-city-of-elk-for-2024-20/ 2024-12-02T11:08:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-of-depressive-disorders-for-children-and-adolescents-aged-10-19-in-the-city-of-krosno-for-the-period-2027-2028/ 2024-12-02T11:08:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-15-2024-on-28-november-2024/ 2024-12-02T11:10:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-of-incontinence-among-female-residents-of-poznan-aged-30-for-2025-2027/ 2024-12-02T11:12:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-talvey-talquetamab/ 2024-12-02T11:15:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-libtayo-cemiplimab-2/ 2024-12-02T11:18:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-libtayo-cemiplimab-3/ 2024-12-02T11:19:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-tavneos-avacopan/ 2024-12-02T11:21:55+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-xmtvi-maxamum/ 2024-12-02T11:23:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-trandate-labetalol/ 2024-12-02T11:25:36+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-49-2024-on-25-november-2024/ 2024-12-02T11:26:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-pomalidomide/ 2024-12-02T11:28:53+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-the-tariff-council-meeting/ 2024-12-02T11:32:14+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-51-2024-w-dniu-09-12-2024-r/ 2024-12-03T08:50:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-pomalidomide-2/ 2024-12-06T08:37:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-fruitivits/ 2024-12-06T12:34:21+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-luxturna-woretygen-neparwowek/ 2024-12-06T12:56:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-voxzogo-wosorytyd/ 2024-12-06T12:58:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-elrexfio-elranatamab/ 2024-12-06T12:59:54+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-badania-przesiewowe-w-kierunku-hipercholesterolemii-rodzinnej-realizowane-jako-element-badania-bilansowego-wykonywanego-na-etapie-rocznego-obowiazkowego-przygotowania-przedszkol/ 2024-12-06T13:01:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-libtayo-cemiplimabum/ 2024-12-06T13:03:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-libtayo-cemiplimab-2/ 2024-12-06T13:06:09+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-talvey-talkwetamab/ 2024-12-06T13:38:30+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-filsuvez-ekstrakt-kory-brzozowej/ 2024-12-06T13:43:42+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-tavneos-awakopan/ 2024-12-06T13:48:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-52-2024-w-dniu-16-12-2024-r/ 2024-12-06T15:48:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-51-2024-w-dniu-09-12-2024-r-aktualizacja/ 2024-12-06T16:33:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-41-2024-w-dniu-30-09-2024-r-aktualizacja/ 2024-12-06T16:35:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa/ 2024-12-07T09:19:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami/ 2024-12-07T09:21:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/podtrzymanie-stanowiska-prezesa-aotmit-w-sprawie-bialej-ksiegi-szczepien-hpv/ 2024-12-09T10:01:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-51-2024-on-9-december-2024/ 2024-12-09T11:32:45+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-fruitivits/ 2024-12-09T11:34:39+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-luxturna-voretigene-neparvovec/ 2024-12-09T11:37:05+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-voxzogo-vosoritide/ 2024-12-09T11:39:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-elrexfio-elranatamab/ 2024-12-09T11:41:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-screening-for-familial-hypercholesterolemia-performed-as-part-of-the-balance-examination-performed-at-the-stage-of-one-year-compulsory-preschool-preparation/ 2024-12-09T11:43:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-libtayo-cemiplimab/ 2024-12-09T11:45:12+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-libtayo-cemiplimab-2/ 2024-12-09T11:47:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-xmtvi-maxamum/ 2024-12-09T11:49:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-xmtvi-maxamum/ 2024-12-09T11:49:45+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-talvey-talquetamab/ 2024-12-09T11:51:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-filsuvez-birch-bark-extract/ 2024-12-09T11:53:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-tavneos-avacopan/ 2024-12-09T11:55:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-52-2024-on-the-16-december-2024/ 2024-12-09T11:56:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-51-2024-on-the-9-december-2024/ 2024-12-09T11:58:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa/ 2024-12-09T12:02:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-on-december/ 2024-12-09T12:07:00+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/reiterate-the-position-of-the-president-of-aotmit-on-the-hpv-vaccination-white-paper/ 2024-12-09T12:09:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-16-2024-w-dniu-12-12-2024-r/ 2024-12-11T07:24:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-51-2024-w-dniu-9-grudnia-2024-roku/ 2024-12-12T08:37:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-lorenzos-oil/ 2024-12-12T08:49:50+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-vabinxo-walsartan-indapamid/ 2024-12-12T08:53:56+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-oxervate-cenegermina/ 2024-12-12T08:57:03+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-cholecalciferolum/ 2024-12-12T09:04:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-risedronatum-natricum/ 2024-12-12T09:07:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-azathioprinum-3/ 2024-12-12T09:10:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-cyclophosphamidum-2/ 2024-12-12T09:12:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-acidum-folicum-3/ 2024-12-12T09:15:50+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-calcort/ 2024-12-12T12:19:04+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/23774/ 2024-12-12T12:22:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-50-2024-w-dniu-2-grudnia-2024-roku/ 2024-12-12T12:24:30+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-reagila-cariprazinum/ 2024-12-12T12:25:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-tolutris-telmisartanum-amlodipini-besilas-hydrochlorothiazidum/ 2024-12-12T12:26:09+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-brentuksymab-vedotin-2/ 2024-12-12T12:26:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-veoza/ 2024-12-12T12:27:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-proglicem/ 2024-12-12T12:28:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-brentuksymab-vedotin/ 2024-12-12T12:28:36+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-reagila-kariprazyna/ 2024-12-13T09:14:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-12-grudnia-2024-r/ 2024-12-13T09:56:49+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-trandate-labetalol-2/ 2024-12-13T11:07:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-veoza-fezolinetant-2/ 2024-12-13T11:09:21+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-profilaktyki-nadwagi-i-otylosci-u-dzieci-z-terenu-wojewodztwa-lodzkiego/ 2024-12-13T11:20:53+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-gminny-program-polityki-zdrowotnej-w-zakresie-przeciwdzialania-zakazeniom-meningokokowym-w-kozach-na-lata-2025-2026/ 2024-12-13T11:23:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-fizykoterapii-i-fizjoterapii-na-lata-2025-2027/ 2024-12-13T11:25:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-dzienny-dom-opieki-medycznej-w-gminie-miejskiej-krakow/ 2024-12-13T11:27:14+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-53-2024-w-dniu-23-12-2024-r/ 2024-12-17T05:47:48+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-16-2024-on-12-december-2024/ 2024-12-17T08:07:41+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-51-2024-on-9-december-2024/ 2024-12-17T08:09:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-m-typer/ 2024-12-17T08:17:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-m-typer/ 2024-12-17T08:17:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-lorenzos-oil/ 2024-12-17T08:20:48+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-vabinxo-valsartan-indapamide/ 2024-12-17T08:22:55+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-oxervate-cenegermin/ 2024-12-17T08:24:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-cholecalciferolum/ 2024-12-17T08:26:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-risedronatum-natricum/ 2024-12-17T08:29:14+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-azathioprinum-3/ 2024-12-17T08:32:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-cyclophosphamidum-2/ 2024-12-17T08:34:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-acidum-folicum-2/ 2024-12-17T08:36:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-chenodeoxycholic-acid-leadiant-chenodeoxycholic-acid/ 2024-12-17T08:40:00+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-on-ppz-48aa-type-2-diabetes-prevention/ 2024-12-17T08:42:50+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-tariff-council-on-12-december-2024/ 2024-12-17T09:28:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-reagila-cariprazine/ 2024-12-17T09:35:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-trandate-labetalol/ 2024-12-17T09:38:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-veoza-fezolinetant-2/ 2024-12-17T09:40:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-the-prevention-of-overweight-and-obesity-in-children-from-the-province-of-lodz/ 2024-12-17T09:42:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-municipal-health-policy-program-for-prevention-of-meningococcal-infections-in-goats-for-2025-2026/ 2024-12-17T09:44:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-rehabilitation-physical-therapy-and-physiotherapy-for-2025-2027/ 2024-12-17T09:46:19+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-day-care-home-in-the-municipality-of-krakow/ 2024-12-17T09:47:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-on-december-2/ 2024-12-17T09:54:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-53-2024-on-23-december-2024/ 2024-12-17T09:58:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-2/ 2024-12-17T11:02:39+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-2/ 2024-12-17T11:03:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-proglicem-diazoksyd-2/ 2024-12-18T11:30:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-proglicem-diazoxide/ 2024-12-18T11:33:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-on-hpp-48aa-breast-cancer-prevention/ 2024-12-19T10:50:23+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-chenodeoxycholic-acid-leadiant-chenodeoxycholic-acid/ 2024-12-20T07:31:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-chenodeoxycholic-acid-leadiant-kwas-chenodeoksycholowy-2/ 2024-12-20T07:32:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-jardiance-empagliflozinum-2/ 2024-12-20T11:25:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-jardiance-empagliflozinum-3/ 2024-12-20T11:28:31+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-jardiance-empagliflozinum-4/ 2024-12-20T11:31:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-renastep-2/ 2024-12-20T11:34:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-test-hpv-hr-z-genotypowaniem-hrhpv/ 2024-12-20T11:37:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-talzenna-talazoparyb/ 2024-12-20T11:41:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-flekainid/ 2024-12-20T11:44:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-budesonidum-5/ 2024-12-20T11:49:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-52-2024-w-dniu-16-grudnia-2024-roku/ 2024-12-20T11:52:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-calcort-deflazakort-4/ 2024-12-20T13:26:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-vabinxo-walsartan-indapamid/ 2024-12-20T13:28:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-renastep-2/ 2024-12-20T13:30:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-w-zakresie-ppz-48aa-profilaktyka-raka-piersi/ 2024-12-20T13:38:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-w-zakresie-48aa-profilaktyka-cukrzycy-typu-2/ 2024-12-20T13:39:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-2/ 2024-12-20T15:50:58+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-3/ 2024-12-20T15:51:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-renastep/ 2024-12-23T06:53:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-3/ 2024-12-23T06:59:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-vabinxo-valsartan-indapamide/ 2024-12-23T07:02:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-calcort-deflazacort/ 2024-12-23T07:04:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-budesonideum/ 2024-12-23T07:14:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-52-2024-on-16-december-2024/ 2024-12-23T07:16:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-flecainide/ 2024-12-23T07:18:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-jardiance-empagliflozin/ 2024-12-23T07:20:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-jardiance-empagliflozin-2/ 2024-12-23T07:22:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-jardiance-empagliflozin-3/ 2024-12-23T07:24:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-renastep-2/ 2024-12-23T07:25:50+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-hpv-hr-test-with-hrhpv/ 2024-12-23T07:27:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-talzenna-talazoparib/ 2024-12-23T07:29:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-oxervate-cenegermina/ 2024-12-23T11:03:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-oxervate-cenegermin/ 2024-12-23T11:06:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-przedluzenie-terminu-przekazania-danych-o-wynagrodzeniach-osob-zatrudnionych-w-podmiotach-leczniczych-3/ 2024-12-27T10:55:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/80-gromadzenie-danych-wynagrodzeniach/ 2024-12-27T10:55:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-3/ 2024-12-27T13:42:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-4/ 2024-12-27T13:42:57+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-4/ 2024-12-27T13:47:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/stan-prac-nad-zleceniami-4/ 2024-12-27T13:51:45+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-on-december-3/ 2024-12-27T13:53:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-wsparcia-diagnostyki-i-leczenia-nieplodnosci-na-terenie-wojewodztwa-dolnoslaskiego-2/ 2024-12-31T07:08:49+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-profilaktyki-i-wczesnego-wykrywania-ryzyka-wystapienia-nowotworu-gruczolu-krokowego-metoda-sekwencjonowania-genow-dla-mieszkancow-gminy-miasta-t/ 2024-12-31T07:24:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-rehabilitacja-pacjentow-onkologicznych-z-terenu-wojewodztwa-swietokrzyskiego/ 2024-12-31T07:26:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-wczesnego-wykrywania-astmy-i-zmian-zapalnych-w-ukladzie-oddechowym-u-dzieci-w-srodowisku-zanieczyszczenia-powietrza-w-kontekscie-przebytej-pande/ 2024-12-31T07:28:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-rozszerzenie-dostepu-do-swiadczen-zdrowotnych-dla-mieszkancow-wroclawia-pn-zdrowie-intymne/ 2024-12-31T07:29:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-jardiance/ 2024-12-31T07:35:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-talzenna-talazoparyb-2/ 2024-12-31T07:36:30+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-test-hpv-hr-z-genotypowaniem-hrhpv-obejmujacym-co-najmniej-typy-16-i-18/ 2024-12-31T07:41:43+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-lorenzos-oil/ 2024-12-31T07:48:09+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-flekainid/ 2024-12-31T07:49:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-dezacor-deflazakort/ 2024-12-31T08:25:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/rekomendacja-prezesa-lorenzos-oil-2/ 2024-12-31T08:34:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-jardiance-empagliflozin/ 2024-12-31T08:36:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-talzenna-talazoparib/ 2024-12-31T08:38:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-hpv-hr-test-with-hrhpv-genotyping-including-at-least-types-16-and-18/ 2024-12-31T08:40:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-flecainide/ 2024-12-31T08:42:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-dezacor-deflazacort/ 2024-12-31T08:45:06+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-in-support-of-diagnosis-and-treatment-of-infertility-in-the-lower-silesian-province-2/ 2024-12-31T08:47:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-szkola-rodzenia-program-edukacji-przedporodowej-dla-przyszlych-rodzicow-w-gminie-debrzno-na-lata-2024-2026/ 2024-12-31T08:52:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-on-prevention-and-early-detection-of-prostate-cancer-risk-by-gene-sequencing-for-residents-of-the-municipality-of-torun-for-2025-2029/ 2024-12-31T08:55:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-childbirth-school-antenatal-education-program-for-parents-to-be-in-the-municipality-of-debrzno-for-2024-2026/ 2024-12-31T08:55:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-rehabilitation-of-oncology-patients-from-the-territory-of-the-swietokrzyskie-province/ 2024-12-31T08:57:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-early-detection-of-asthma-and-inflammatory-changes-of-the-respiratory-system-in-children-in-the-environment-of-air-pollution-in-the-context-of-the/ 2024-12-31T08:59:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-expanding-access-to-health-services-for-residents-of-wroclaw-called-intimate-health/ 2024-12-31T09:00:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-jardiance-empagliflozinum-3/ 2024-12-31T10:14:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-jardiance-empagliflozinum-4/ 2024-12-31T11:05:54+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-53-2024-w-dniu-23-grudnia-2024-roku/ 2024-12-31T11:07:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-wzmacniana-proteza-zebowa-pacjent-z-epilepsja/ 2024-12-31T11:10:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-lokelma-sodu-cyrkonu-cyklokrzemian/ 2024-12-31T11:12:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-emcitate-tiratricol/ 2024-12-31T11:13:34+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-quviviq-daridoreksant/ 2024-12-31T11:14:57+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-jardiance-empagliflozin-2/ 2024-12-31T11:15:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-dezacor-deflazakort/ 2024-12-31T11:16:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-revestive-teduglutyd/ 2024-12-31T11:17:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-jardiance-empagliflozin-3/ 2024-12-31T11:18:03+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-w-zakresie-ppz-48aa-profilaktyka-zakazen-meningokokowych/ 2024-12-31T11:54:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-1-2025-w-dniu-07-01-2025-r/ 2025-01-03T06:56:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-tolutris-telmisartan-amlodypina-hydrochlorotiazyd/ 2025-01-07T09:48:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-emcitate-tyratrykol/ 2025-01-07T09:50:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-2-2025-w-dniu-13-01-2025-r/ 2025-01-07T11:05:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-53-2024-on-23-december2024/ 2025-01-08T08:57:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-reinforced-dentures-patient-with-epilepsy/ 2025-01-08T08:59:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-on-hpp-48aa-prevention-of-meningococcal-infections/ 2025-01-08T09:03:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-lokelma-sodium-zirconium-cyclosilicate/ 2025-01-08T09:06:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-emcitate-tiratricol/ 2025-01-08T09:08:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-quviviq-daridorexant/ 2025-01-08T09:17:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-dezacor-deflazacort/ 2025-01-08T13:33:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-revestive-teduglutide/ 2025-01-08T13:35:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-1-2025-on-7-january-2025/ 2025-01-08T13:37:14+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-tolutris-telmisartan-amlodipine-hydrochlorothiazide/ 2025-01-08T13:39:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-emcitate-tiratricol/ 2025-01-08T13:41:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-2-2025-on-13-january-2025/ 2025-01-08T13:42:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-reinforced-dentures-patient-with-epilepsy/ 2025-01-08T13:52:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-wzmacniana-proteza-zebowa-pacjent-z-epilepsja/ 2025-01-08T13:52:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-lokelma-cyklokrzemian-sodowo-cyrkonowy/ 2025-01-08T13:54:08+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-lokelma-sodium-zirconium-cyclosilicate/ 2025-01-08T13:56:03+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-quviviq-daridoreksant/ 2025-01-09T13:14:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-quviviq-daridorexant/ 2025-01-09T14:33:56+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-3-2025-w-dniu-20-01-2025-r/ 2025-01-10T18:16:42+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-2-2025-w-dniu-13-01-2025-r-aktualizacja/ 2025-01-10T18:28:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-2-2025-on-13-january-2025-2/ 2025-01-13T08:53:47+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-3-2025-on-20-january-2025/ 2025-01-13T09:48:12+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-forxiga-dapagliflozin-3/ 2025-01-13T10:24:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-cholestyramine/ 2025-01-13T10:26:05+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-attentin-dextroamphetamine/ 2025-01-13T10:27:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-cytology-screening-classic-cytology/ 2025-01-13T10:40:56+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-cytologia-klasyczna/ 2025-01-13T11:16:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-attentin-dextroamphetamine/ 2025-01-13T11:16:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-cholestyramina/ 2025-01-13T11:17:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-forxiga-dapagliflozinum/ 2025-01-13T11:18:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-alecensa-alektynib/ 2025-01-14T06:03:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-revestive-teduglutyd/ 2025-01-14T14:13:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-revestive-teduglutide/ 2025-01-14T14:16:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-alecensa-alectinib/ 2025-01-14T14:18:23+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-1-2025-on-7-january-2025/ 2025-01-14T14:19:54+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-1-w-dniu-7-stycznia-2025-roku/ 2025-01-14T14:20:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-cholestyramina/ 2025-01-17T07:53:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-cholestyramine/ 2025-01-17T07:55:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-1-2025-w-dniu-7-stycznia-2025-roku/ 2025-01-17T08:47:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-ocrevus-ocrelizumabum/ 2025-01-17T08:54:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-vigabatrinum/ 2025-01-17T09:03:53+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-azathioprinum-4/ 2025-01-17T09:14:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-acidum-mycophenolicum/ 2025-01-17T09:15:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-everolimusum/ 2025-01-17T09:17:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-tacrolimusum-4/ 2025-01-17T09:19:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-sirolimusum-4/ 2025-01-17T09:21:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-5/ 2025-01-17T09:46:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-2-2025-on-13-january-2025/ 2025-01-17T10:48:23+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-ocrevus-ocrelizumab/ 2025-01-17T10:50:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-vigabatrinum/ 2025-01-17T10:53:28+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-acidum-mycophenolicum/ 2025-01-17T10:55:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-azathioprinum-4/ 2025-01-17T10:56:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-everolimusum/ 2025-01-17T10:58:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-tacrolimusum/ 2025-01-17T10:59:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-sirolimusum/ 2025-01-17T11:00:31+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-5/ 2025-01-17T11:31:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-nastroimy-lodzkie/ 2025-01-20T13:44:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-kompleksowy-program-przeciwdzialania-nadwadze-i-otylosci-u-dzieci-i-mlodziezy-w-wojewodztwie-pomorskim/ 2025-01-20T13:47:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-niedoboru-witaminy-d-wsrod-mieszkancow-wojewodztwa-mazowieckiego/ 2025-01-20T13:51:11+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-nastroimy-lodzkie/ 2025-01-21T07:36:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-comprehensive-program-to-prevent-overweight-and-obesity-in-children-and-adolescents-in-pomeranian-province/ 2025-01-21T07:45:09+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-odd-waga-kompleksowe-leczenie-nadwagi-i-otylosci-u-dzieci-i-mlodziezy/ 2025-01-21T07:45:31+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-bravery-comprehensive-treatment-of-overweight-and-obesity-in-children-and-adolescents/ 2025-01-21T07:47:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-vitamin-d-deficiency-among-the-inhabitants-of-the-mazovian-province/ 2025-01-21T07:48:58+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-21-stycznia-2025-r/ 2025-01-23T10:38:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-4-2025-w-dniu-27-01-2025-r/ 2025-01-23T10:41:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-ocrevus-okrelizumab-2/ 2025-01-23T11:18:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-forxiga-dapagliflozyna-5/ 2025-01-23T11:19:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-alecensa-alektynib/ 2025-01-23T11:20:42+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-przesiewowe-badanie-cytologiczne-cytologia-klasyczna/ 2025-01-23T11:22:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-forxiga-dapagliflozyna-6/ 2025-01-24T05:45:31+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-4/ 2025-01-24T05:49:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-hyqvia-immunoglobulina-ludzka-normalna-z-rekombinowana-ludzka-hialuronidaza/ 2025-01-24T05:52:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-nucala-mepolizumab-2/ 2025-01-24T05:55:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-rythmodan-dyzopiramid/ 2025-01-24T05:58:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-6/ 2025-01-24T15:11:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-aotmit-w-sprawie-przekazywania-informacji-dotyczacych-pico-na-rzecz-wspolnych-ocen-klinicznych/ 2025-01-27T10:31:28+00:00 https://www.aotm.gov.pl/wp-content/uploads/2025/01/Komunikat-JCA-1.png https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-forxiga-dapagliflozin/ 2025-01-27T14:21:00+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-ocrevus-ocrelizumab/ 2025-01-27T14:23:19+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-alecensa-alectinib/ 2025-01-27T14:25:19+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-cytology-screening-classic-cytology/ 2025-01-27T14:28:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-on-21-january-2025/ 2025-01-27T14:33:03+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-5-2025-w-dniu-03-02-2025-r/ 2025-01-28T10:12:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-4-2025-on-27-january-2025/ 2025-01-28T12:21:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-forxiga-dapagliflozin-4/ 2025-01-28T12:23:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-verzenios-abemaciclib-2/ 2025-01-28T12:25:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-hyqvia-human-normal-immunoglobulin/ 2025-01-28T12:27:31+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-nucala-mepolizumab-2/ 2025-01-28T12:29:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-rythmodan-disopyramide/ 2025-01-28T12:32:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-5-2025-on-3-february-2025/ 2025-01-28T12:35:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-on-january/ 2025-01-28T12:46:11+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-5/ 2025-01-28T12:47:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-4-2025-w-dniu-27-stycznia-2025-roku/ 2025-01-29T11:56:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-3-2025-w-dniu-20-stycznia-2025-roku-2/ 2025-01-29T12:06:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-keytruda-pembrolizumab-5/ 2025-01-29T12:10:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-actimodan-modafinil/ 2025-01-29T12:21:48+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-litfulo-ritlecytynib/ 2025-01-29T12:25:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-rubraca-rukaparyb/ 2025-01-29T12:31:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-4-2025-on-27-january-2025/ 2025-01-31T10:40:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-3-2025-on-20-january-2025-2/ 2025-01-31T10:42:05+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-3-2025-on-20-january-2025/ 2025-01-31T10:44:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-keytruda-pembrolizumab-4/ 2025-01-31T10:46:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-actimodan-modafinil/ 2025-01-31T10:48:32+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-litfulo-ritlecitinib/ 2025-01-31T10:53:39+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-rubraca-rucaparib/ 2025-01-31T10:56:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-hyqvia-immunoglobulina-ludzka-normalna-z-rekombinowana-ludzka-hialuronidaza/ 2025-01-31T12:07:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-hyqvia-human-normal-immunoglobulin/ 2025-01-31T12:08:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-7/ 2025-01-31T12:15:39+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-6/ 2025-01-31T12:36:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/24323/ 2025-01-31T12:37:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-chorob-odstresowych-u-osob-pracujacych-na-terenie-wojewodztwa-malopolskiego-2/ 2025-01-31T13:15:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-kolczyglowy-na-lata-2025-2027/ 2025-01-31T13:27:19+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-pokoj-na-lata-2025-2030/ 2025-01-31T13:28:42+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-raport-z-oceny-efektywnosci-tli-3/ 2025-01-31T15:45:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-for-prevention-of-stress-disorders-in-working-people-in-the-malopolska-province/ 2025-02-03T08:47:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-in-the-field-of-medical-rehabilitation-of-the-inhabitants-of-the-municipality-of-kolczyglowy-for-2025-2027/ 2025-02-03T08:49:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-medical-rehabilitation-of-residents-of-the-municipality-of-peace-for-2025-2030/ 2025-02-03T08:51:19+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-attentin-dextroamphetamine/ 2025-02-04T08:00:32+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-attentin-dextroamphetamine/ 2025-02-04T08:06:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-actimodan-modafinil/ 2025-02-05T09:57:26+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-actimodan-modafinil/ 2025-02-05T09:57:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-litfulo-ritlecytynib/ 2025-02-05T09:58:12+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-litfulo-ritlecitinib/ 2025-02-05T09:58:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-6-2025-w-dniu-10-02-2025-r/ 2025-02-05T13:08:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-verzenios-abemacyklib/ 2025-02-06T09:43:40+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-verzenios-abemaciclib/ 2025-02-06T09:46:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-6-2025-on-10-february-2025/ 2025-02-06T09:47:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-rubraca-rukaparyb/ 2025-02-06T09:49:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-rubraca-rucaparib/ 2025-02-06T09:52:21+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-forxiga-dapagliflozyna-6/ 2025-02-07T09:05:33+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-keytruda-pembrolizumab-4/ 2025-02-07T09:07:32+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-forxiga-dapagliflozin-2/ 2025-02-07T09:30:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-keytruda-pembrolizumab-2/ 2025-02-07T09:32:19+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-methylphenidat/ 2025-02-07T16:40:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-leczenie-mukopolisacharydozy-typu-ii-zespol-huntera/ 2025-02-07T16:45:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-paklitaksel/ 2025-02-07T16:52:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-keytruda-pembrolizumab-5/ 2025-02-17T12:51:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-keytruda-pembrolizumab-6/ 2025-02-17T12:49:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-methylphenidate/ 2025-02-10T10:28:39+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-treatment-of-mucopolysaccharidosis-type-ii-hunter-syndrome-icd-10-e76-1/ 2025-02-10T10:32:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-paclitaxel-2/ 2025-02-10T10:33:44+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-7-2025-w-dniu-17-02-2025-r/ 2025-02-11T06:34:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-metylofenidat/ 2025-02-13T12:29:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-zasadnosc-wprowadzenia-zmian-w-ramach-programu-lekowego-b-25-leczenie-mukopolisacharydozy-typu-ii-zespol-huntera/ 2025-02-13T12:32:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-zasadnosc-wprowadzenia-zmian-w-ramach-programu-lekowego-b-71-leczenie-terapia-bezinterferonowa-chorych-na-przewlekle-wirusowe-zapalenie-watroby-typu-c/ 2025-02-13T12:35:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-kladrybina/ 2025-02-14T05:21:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-sirolimusum-5/ 2025-02-14T05:46:58+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-ciclosporinum-2/ 2025-02-14T05:50:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/24455/ 2025-02-14T06:11:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-danazolum/ 2025-02-14T06:14:49+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-valganciclovirum/ 2025-02-14T06:18:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-leczenie-terapia-bezinterferonowa-chorych-na-przewlekle-wirusowe-zapalenie-watroby-typu-c-icd-10-b18-2/ 2025-02-14T06:34:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-6-2025-w-dniu-10-lutego-2025-roku/ 2025-02-14T07:31:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-poprawy-opieki-nad-matka-i-dzieckiem-w-wojewodztwie-opolskim-w-latach-2025-2027/ 2025-02-14T07:53:36+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-regionalny-program-zdrowotny-w-zakresie-rehabilitacji-medycznej-schorzen-ukladu-ruchu-i-obwodowego-ukladu-nerwowego-zwiazanych-ze-sposobem-wykonywania-pracy-skierowany-do-osob-pracu/ 2025-02-14T07:55:02+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-2-2025-w-dniu-20-02-2025-r/ 2025-02-14T10:33:14+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenia-rady-do-spraw-taryfikacji-1-2025-w-dniu-21-01-2025-r/ 2025-02-14T10:45:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-7-2025-on-17-february-2025/ 2025-02-17T08:44:33+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-methylphenidate/ 2025-02-17T08:47:36+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-treatment-of-mucopolysaccharidosis-type-ii-hunter-syndrome/ 2025-02-17T08:49:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-treatment-of-patients-with-chronic-hepatitis-c-with-non-interferon-therapy/ 2025-02-17T08:53:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-kladrybina/ 2025-02-17T08:55:44+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-zasadnosc-wprowadzenia-zmian-dla-kladrybiny-w-ramach-programu-l/ 2025-02-17T08:55:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-skyclarys-omaveloxolone/ 2025-02-17T08:57:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-skyclarys-omaweloksolon/ 2025-02-17T08:58:06+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-multiple-sclerosis/ 2025-02-17T09:08:00+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-sirolimusum-2/ 2025-02-17T09:13:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-ciclosporin/ 2025-02-17T09:16:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-cyclophosphamide/ 2025-02-17T09:18:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-danazolum/ 2025-02-17T09:20:46+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-valganciclovir/ 2025-02-17T09:22:02+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-treatment-with-interferon-free-therapy-of-patients-with-chronic-hepatitis-c/ 2025-02-17T09:23:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-6-2025-on-10-february-2025/ 2025-02-17T09:24:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-to-improve-the-care-of-mothers-and-children-in-the-opole-province-in-the-years-2025-2027/ 2025-02-17T11:08:32+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-regional-health-program-in-the-field-of-medical-rehabilitation-of-work-related-musculoskeletal-and-peripheral-nervous-system-disorders-addressed-to-working-and-returning-to/ 2025-02-17T11:10:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-2-2025-on-20-february-2025/ 2025-02-17T11:11:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-keytruda-pembrolizumabum-w-skojarzeniu-z-chemioterapia/ 2025-02-17T12:49:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-keytruda-pembrolizumabum-monoterapia/ 2025-02-17T12:51:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-3-2025-w-dniu-20-stycznia-2025-roku/ 2025-02-17T12:52:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-5-2025-w-dniu-3-lutego-2025-roku/ 2025-02-17T12:57:39+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-dyzopiramid/ 2025-02-19T09:15:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-7-2025-w-dniu-24-02-2025-r/ 2025-02-19T09:48:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-5-2025-on-3-february-2025/ 2025-02-19T10:07:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-dysopyramide/ 2025-02-19T10:08:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-8-2025-on-24-february-2025/ 2025-02-19T10:09:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-sorafenib/ 2025-02-19T13:21:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-7-2025-w-dniu-17-lutego-2025-roku/ 2025-02-19T13:24:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-sorafenib/ 2025-02-20T09:01:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-7-2025-on-17-february-2025/ 2025-02-20T09:03:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-raport-w-sprawie-ustalenia-taryfy-swiadczen-gwarantowanych-z-zakresu-leczenia-szpitalnego-obejmujacych-leczenie-chorob-ukladu-nerwowego-konsultacje-zewnetrzne/ 2025-02-21T10:24:54+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-8/ 2025-02-21T13:09:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-6/ 2025-02-21T13:11:14+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-7/ 2025-02-24T08:03:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-in-february/ 2025-02-24T08:06:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-skyclarys-omaweloksolon/ 2025-02-24T11:30:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-skyclarys-omaveloxolone/ 2025-02-24T11:33:04+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-keytruda-pembrolizumab-5/ 2025-02-25T08:59:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-keytruda-pembrolizumab-3/ 2025-02-25T09:05:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-rehabilitacji-leczniczej-seniorow-mieszkancow-gminy-swieciechowa-w-wieku-od-60-roku-zycia-na-lata-2025-2027/ 2025-02-25T13:27:21+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-wczesnej-diagnostyki-zaburzen-neurorozwojowych-w-populacji-dzieci-w-wieku-0-7-lat-w-pieczy-zastepczej-w-wojewodztwie-lubuskim-2/ 2025-02-25T13:28:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-i-wczesne-wykrywanie-wad-wzroku-u-dzieci-w-wieku-12-lat-zamieszkalych-na-terenie-gminy-opalenica-na-lata-2025-2027/ 2025-02-25T13:30:04+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-z-zakresu-szczepien-przeciwko-polpascowi-profilaktyka-polpasca-oraz-neuralgii-polpascowej-w-populacji-osob-w-wieku-55-lat-i-starszych-na-lata-202/ 2025-02-25T13:31:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-therapeutic-rehabilitation-program-for-seniors-residents-of-the-swieciechowa-commune-aged-60-and-over-for-the-years-2025-2027/ 2025-02-25T13:43:29+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-early-diagnosis-of-neurodevelopmental-disorders-in-the-population-of-children-aged-0-7-in-foster-care-in-the-lubuskie-province/ 2025-02-25T13:44:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-and-early-detection-of-visual-impairments-in-children-aged-12-living-in-the-opalenica-commune-for-the-years-2025-2027/ 2025-02-25T13:46:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-herpes-zoster-vaccination-prevention-of-herpes-zoster-and-herpes-zoster-neuralgia-in-the-population-aged-55-and-over-for-the-period-2025-2027/ 2025-02-25T13:47:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-9-2025-w-dniu-03-03-2025-r/ 2025-02-27T05:55:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-10-2025-w-dniu-10-03-2025-r/ 2025-02-27T12:51:04+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-qinlock-ripretinibum/ 2025-02-28T06:07:58+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-ebglyss-lebrikizumabum/ 2025-02-28T06:14:05+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-vyepti-eptinezumabum/ 2025-02-28T06:17:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-remsima-infliksymab-2/ 2025-02-28T06:25:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-remsima-infliksymab-3/ 2025-02-28T06:28:21+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-remsima-infliksymab-4/ 2025-02-28T06:31:16+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-remsima-infliksymab-5/ 2025-02-28T06:37:24+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-remsima-infliksymab-6/ 2025-02-28T06:40:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-docetaksel/ 2025-02-28T06:44:11+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-8-2025-w-dniu-24-lutego-2025-roku/ 2025-02-28T10:12:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-rozebalamin-mecobalamin/ 2025-02-28T10:17:06+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-rozebalamin-mecobalamin/ 2025-02-28T10:19:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-7/ 2025-02-28T12:56:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/wykaz-lekow-stosowanych-w-onkologii/ 2025-02-28T19:28:43+00:00 https://www.aotm.gov.pl/wp-content/uploads/2025/02/Slajd1.jpg https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-9-2025-on-3-march-2025/ 2025-03-04T09:09:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-qinlock-ripretinib/ 2025-03-04T09:13:14+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-10-2025-on-10-match-2025/ 2025-03-04T09:27:44+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-ebglyss-lebrikizumab/ 2025-03-04T09:30:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-vyepti-eptinezumab/ 2025-03-04T09:36:30+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-remsima-infliksymab/ 2025-03-04T09:54:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-remsima-infliximab/ 2025-03-04T09:54:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-remsima-infliximab-2/ 2025-03-04T09:57:26+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-remsima-infliximab-3/ 2025-03-04T10:01:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-remsima-infliximab-4/ 2025-03-04T10:04:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-remsima-infliximab-5/ 2025-03-04T10:08:12+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-remsima-infliximab-6/ 2025-03-04T10:12:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-docetaxel/ 2025-03-04T10:16:31+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-8-2025-on-24-february-2025/ 2025-03-04T10:20:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-in-february-2/ 2025-03-04T10:24:38+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-10-2025-w-dniu-10-03-2025-r-aktualizacja/ 2025-03-05T08:57:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-ebglyss-lebrykizumab/ 2025-03-05T09:38:31+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-9-2025-w-dniu-3-marca-2025-roku/ 2025-03-06T05:32:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-testowanie-przesiewowe-anty-hiv-testem-przesiewowym-iv-generacji/ 2025-03-06T05:45:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-on-10-march-2025-update/ 2025-03-06T08:18:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-ebglyss-lebrikizumab/ 2025-03-06T08:21:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-9-2025-on-3-march-2025/ 2025-03-06T08:23:02+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-introduction-of-anti-hiv-screening-with-a-fourth-generation-screening-test/ 2025-03-06T08:29:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-my-health-adult-health-check/ 2025-03-06T08:31:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-mma-pa-anamix-infant-mma-pa-anamix-junior-mma-pa-gel-mma-pa-express-15-mma-pa-cooler-15/ 2025-03-06T08:32:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-vyepti-eptinezumab/ 2025-03-06T08:35:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-vyepti-eptinezumab/ 2025-03-06T08:35:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-moje-zdrowie-bilans-zdrowia-osoby-doroslej/ 2025-03-06T08:49:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-mma-pa/ 2025-03-06T08:49:50+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-qinlock-ripretynib/ 2025-03-06T10:30:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-qinlock-ripretinib/ 2025-03-06T10:36:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-fasenra-benralizumab/ 2025-03-06T13:45:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-11-2025-w-dniu-17-03-2025-r/ 2025-03-07T11:12:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-ozarow-na-lata-2025-2026/ 2025-03-07T12:06:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-9/ 2025-03-07T17:51:02+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-11-2025-on-17-march-2025/ 2025-03-10T08:50:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-therapeutic-rehabilitation-of-the-residents-of-the-ozarow-commune-for-the-years-2025-2026/ 2025-03-10T08:54:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-8/ 2025-03-10T08:59:56+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-8/ 2025-03-10T09:11:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-moje-zdrowie-bilans-zdrowia-osoby-doroslej/ 2025-03-10T13:32:43+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-wprowadzenie-testowania-przesiewowego-anty-hiv-testem-przesiewowym-iv-generacji/ 2025-03-10T13:35:21+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-rozebalamin-mecobalamin/ 2025-03-12T08:45:18+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-remsima-infliksymab/ 2025-03-12T08:51:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-remsima-infliksymab-2/ 2025-03-12T08:55:44+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-remsima-infliksymab-3/ 2025-03-12T08:59:15+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-remsima-infliksymab-4/ 2025-03-12T09:02:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-szczepien-przeciwko-krztuscowi-w-malopolsce/ 2025-03-12T11:18:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-10-2025-w-dniu-10-marca-2025-roku/ 2025-03-13T05:32:20+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-prednisolonum/ 2025-03-13T05:46:26+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-posaconazolum-4/ 2025-03-13T05:48:57+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-9/ 2025-03-13T05:51:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-tacrolimusum-5/ 2025-03-13T05:53:47+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-mma-pa-anamix-infant-mma-pa-anamix-junior-mma-pa-gel-mma-pa-express-15-mma-pa-cooler-15/ 2025-03-13T16:04:13+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-11-2025-w-dniu-17-03-2025-r-aktualizacja/ 2025-03-14T06:09:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-ds-taryfikacji-uklad-nerwowy/ 2025-03-17T13:19:38+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-tariff-council-nervous-system/ 2025-03-17T13:25:53+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-10/ 2025-03-17T13:26:32+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-3-2025-w-dniu-20-03-2025-r/ 2025-03-18T05:26:19+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-fasenra-benralizumab-2/ 2025-03-18T09:13:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-12-2025-w-dniu-24-03-2025-r/ 2025-03-18T10:06:12+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-my-health-adult-health-check/ 2025-03-18T10:43:53+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president/ 2025-03-18T10:46:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-rozebalamin-mecobalamin/ 2025-03-18T10:49:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-remsima-infliximab/ 2025-03-18T10:52:09+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-remsima-infliximab-2/ 2025-03-18T10:53:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-remsima-infliximab-3/ 2025-03-18T10:56:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-remsima-infliximab-4/ 2025-03-18T10:57:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-whooping-cough-vaccination-in-the-malopolska-region/ 2025-03-18T10:59:41+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-10-2025-on-10-march-2025/ 2025-03-18T11:01:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-posaconazole/ 2025-03-18T11:04:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-prednisolone/ 2025-03-18T11:04:15+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-sirolimusum-3/ 2025-03-18T11:05:35+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-tacrolimusum-2/ 2025-03-18T11:11:25+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-mma-pa-anamix-infant-mma-pa-anamix-junior-mma-pa-gel-mma-pa-express-15-mma-pa-cooler-15/ 2025-03-18T11:14:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-11-2025-on-17-march-2025-update/ 2025-03-18T11:16:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-9/ 2025-03-18T11:20:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-3-2025-on-20-march-2025/ 2025-03-18T11:22:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-fasenra-benralizumab/ 2025-03-18T11:24:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-12-2025-on-24-march-2025/ 2025-03-18T11:27:06+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-briumvi-ublituksymab/ 2025-03-20T07:12:52+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-sulfamethoxazolum-trimethoprimum-2/ 2025-03-20T07:28:44+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-netupitant-palonosetron/ 2025-03-20T07:31:22+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-11/ 2025-03-21T17:48:11+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-9/ 2025-03-21T17:48:31+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-13-2025-w-dniu-31-03-2025-r/ 2025-03-24T05:08:08+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-20-lutego-2025-r/ 2025-03-25T09:03:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-briumvi-ublituximab/ 2025-03-26T07:24:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-sulfamethoxazolum-trimethoprimum/ 2025-03-26T07:27:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-netupitant-palonosetron/ 2025-03-26T07:30:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-13-2025-on-31-march-2025/ 2025-03-26T07:32:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-10/ 2025-03-26T07:38:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-in-february-3/ 2025-03-26T07:41:28+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-in-march/ 2025-03-26T07:45:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-profilaktyka-zaburzen-depresyjnych-dla-dzieci-i-mlodziezy-w-wieku-12-15-lat-na-terenie-gminy-miasto-jozefow-na-lata-2025-2026/ 2025-03-26T14:33:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-i-wczesnego-wykrywania-wad-wzroku-dla-uczniow-klas-iii-szkol-podstawowych-zlokalizowanych-na-terenie-miasta-bedzin-na-lata-2025-2027/ 2025-03-26T14:34:16+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-rehabilitacji-leczniczej-mieszkancow-gminy-brzeg-na-lata-2025-2028/ 2025-03-26T14:35:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-i-wczesnego-wykrywania-nadwagi-i-otylosci-wsrod-dzieci-i-mlodziezy-w-powiecie-piaseczynskim-na-lata-2025-2027/ 2025-03-26T14:37:09+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-reblozyl-luspaterceptum/ 2025-03-27T06:09:28+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-erwinase/ 2025-03-27T06:11:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-for-the-prevention-and-early-detection-of-visual-impairments-for-third-grade-primary-school-students-located-in-the-city-of-bedzin-for-the-years-2025-2027/ 2025-03-27T08:24:46+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-prevention-of-depressive-disorders-for-children-and-adolescents-aged-12-15-in-the-municipality-of-jozefow-for-2025-2026/ 2025-03-27T08:42:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-therapeutic-rehabilitation-of-brzeg-municipality-residents-for-2025-2028/ 2025-03-27T08:44:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-for-the-prevention-and-early-detection-of-overweight-and-obesity-among-children-and-adolescents-in-the-piaseczno-district-for-the-years-2025-2027/ 2025-03-27T08:47:35+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-chrzastka_amic/ 2025-03-27T08:50:32+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-cartilage-regeneration-procedures-using-the-amic-technique/ 2025-03-27T08:51:16+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-erwinase-crisantaspasum/ 2025-03-27T08:53:07+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-reblozyl-luspatercept/ 2025-03-27T08:55:36+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-14-2025-w-dniu-07-04-2025-r/ 2025-03-28T08:06:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/wykaz-technologii-lekowych-o-wysokim-poziomie-innowacyjnosci-tli-2/ 2025-03-28T10:52:55+00:00 https://www.aotm.gov.pl/wp-content/uploads/2024/03/AOTM_PRO_-TLI-wykaz-2024-Cv1-1080px.png https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-w-sprawie-posiedzenia-rady-ds-taryfikacji-w-dniu-20-marca-2025-r/ 2025-03-28T11:57:43+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-briumvi-ublituksymab/ 2025-04-01T07:12:41+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-briumvi-ublituximab/ 2025-04-01T07:21:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-14-2025-on-7-april-2025/ 2025-04-01T07:35:36+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/aotmit-wspiera-swiadczeniodawcow-w-procesie-wdrozenia-srk/ 2025-04-01T08:47:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-12-2025-w-dniu-24-marca-2025-roku/ 2025-04-03T04:55:31+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-5/ 2025-04-03T05:14:46+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-voydeya-danikopan/ 2025-04-03T05:18:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-lamprene-klofazymina/ 2025-04-03T05:22:37+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-peginterferonum-alfa-2a-3/ 2025-04-03T05:26:27+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-erwinase-kryzantaspaza/ 2025-04-03T11:53:40+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-procedura-regeneracyjna-chrzastki-z-uzyciem-techniki-amic-rekonstrukcji-chrzastki-stawowej-z-implantacja-skafoldow-wszczepianie-materialow-chrzastko-zastepczych/ 2025-04-03T14:25:23+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-wczesnego-wykrywania-wad-wzroku-u-dzieci-7-letnich-zamieszkujacych-na-terenie-miasta-sieradza/ 2025-04-03T14:28:41+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-profilaktyki-zaburzen-depresyjnych-wsrod-nastolatkow-i-mlodych-doroslych-na-terenie-gminy-radwanice-na-lata-2025-2027/ 2025-04-03T14:29:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-w-zakresie-profilaktyki-nadwagi-i-otylosci-wsrod-uczniow-klas-iv-szkol-podstawowych-w-miescie-suwalki-na-lata-2025-2028/ 2025-04-03T14:30:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-12/ 2025-04-07T09:11:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-12-2025-on-24-march-2025/ 2025-04-07T09:18:26+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-grazax/ 2025-04-07T09:20:18+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-voydeya-danicopan/ 2025-04-07T09:23:21+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-lamprene-clofazimine/ 2025-04-07T09:28:20+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council/ 2025-04-07T09:29:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-erwinase-crysantaspase/ 2025-04-07T09:32:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-cartilage-regeneration-procedures-using-the-amic-technique-articular-cartilage-reconstruction-with-implantation-of-scaffolds-implantation-of-cartilage-replacement/ 2025-04-07T09:33:54+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-early-detection-of-visual-defects-in-7-year-old-children-living-in-the-city-of-sieradz/ 2025-04-07T09:35:27+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-program-for-the-prevention-of-depressive-disorders-among-teenagers-and-young-adults-in-the-radwanice-commune-for-the-years-2025-2027/ 2025-04-07T09:37:28+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-the-prevention-of-overweight-and-obesity-among-fourth-graders-in-primary-schools-in-the-city-of-suwalki-for-the-years-2025-2028/ 2025-04-07T09:38:59+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-11/ 2025-04-07T09:42:44+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-10/ 2025-04-07T09:45:34+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-in-april/ 2025-04-07T09:48:10+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-program-polityki-zdrowotnej-profilaktyki-krztusca-w-wojewodztwie-pomorskim-u-osob-65-z-rozpoznaniem-przewleklych-chorob-pluc/ 2025-04-07T10:12:25+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-prezesa-kompleksowy-program-przeciwdzialania-nadwadze-i-otylosci-u-dzieci-i-mlodziezy-w-wojewodztwie-pomorskim-2/ 2025-04-07T10:13:51+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-health-policy-program-for-the-prevention-of-whooping-cough-in-the-pomeranian-voivodeship-in-people-aged-65-with-diagnosed-chronic-lung-diseases/ 2025-04-07T10:17:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-president-comprehensive-program-to-prevent-overweight-and-obesity-in-children-and-adolescents-in-the-pomorskie-province/ 2025-04-07T10:19:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-15-2025-w-dniu-14-04-2025-r/ 2025-04-08T04:48:04+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-z-posiedzenia-rady-przejrzystosci-nr-13-2025-w-dniu-31-marca-2025-roku/ 2025-04-08T08:29:58+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/communication-of-the-meeting-of-transparency-council-no-13-2025-on-31-march-2025/ 2025-04-08T12:59:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-15-2025-on-14-april-2025/ 2025-04-08T12:59:30+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-mestinon/ 2025-04-09T09:45:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-prednisonum-3/ 2025-04-09T09:59:49+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-haloperidolum/ 2025-04-09T10:12:56+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-10/ 2025-04-09T10:16:01+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-voydeya-danikopan/ 2025-04-11T09:16:07+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-13/ 2025-04-11T16:26:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stan-prac-nad-zleceniami-11/ 2025-04-11T16:27:19+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-przejrzystosci-nr-16-2025-w-dniu-22-04-2025-r/ 2025-04-14T12:12:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/posiedzenie-rady-do-spraw-taryfikacji-4-2025-w-dniu-17-04-2025-r/ 2025-04-16T08:34:36+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-fabhalta-iptacopan/ 2025-04-16T11:27:29+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-tagrisso-osimertinibum/ 2025-04-16T11:34:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-xyrem-hydroksymaslan-sodu/ 2025-04-16T11:38:31+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-albendazol-micro-labs/ 2025-04-16T11:41:17+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-carbamazepinum-3/ 2025-04-16T11:46:51+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-lakozamid-2/ 2025-04-16T11:52:59+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-posaconazolum-5/ 2025-04-16T11:54:55+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-posaconazolum-6/ 2025-04-16T11:57:45+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/opinia-rady-przejrzystosci-peginterferonum-alfa-2a-4/ 2025-04-16T14:31:56+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/rekomendacja-prezesa-lamprene-klofazymina-2/ 2025-04-17T06:14:12+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/publikacja-awa-14/ 2025-04-22T06:41:08+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-mestinon-retard-pyridostigmini-bromidum-and-mestinon-pyridostigmini/ 2025-04-22T06:50:22+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-prednisonum-2/ 2025-04-22T06:54:01+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-haloperidolum/ 2025-04-22T06:56:45+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-olanzapine/ 2025-04-22T06:58:10+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-voydeya-danicopan/ 2025-04-22T07:02:37+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-12/ 2025-04-22T07:07:13+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-in-april-2/ 2025-04-22T07:11:42+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/the-transparency-council-meeting-16-2025-on-22-april-2025/ 2025-04-22T07:13:03+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/tariff-council-meeting-4-2025-on-17-april-2025/ 2025-04-22T07:14:24+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-fabhalta-iptacopan/ 2025-04-22T07:16:38+00:00 https://www.aotm.gov.pl/aktualnosci/najnowsze/stanowisko-rady-przejrzystosci-leczenie-choroby-gauchera-typu-i-oraz-typu-iii-icd-10-e-75-2/ 2025-04-22T07:17:17+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-treatment-of-gaucher-disease-type-i-and-type-iii-icd-10-e-75-2/ 2025-04-22T07:18:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-tagrisso-osimertinib/ 2025-04-22T07:24:04+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-xyrem-sodium-oxybate/ 2025-04-22T07:26:49+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/position-of-the-transparency-council-albendazol-micro-labs/ 2025-04-22T07:30:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-carbamazepine-2/ 2025-04-22T07:32:30+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-peginterferon-alfa-2a/ 2025-04-22T07:34:43+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-lacosamide-2/ 2025-04-22T07:36:02+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-posaconazole-2/ 2025-04-22T07:37:52+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/opinion-of-the-transparency-council-posaconazole-3/ 2025-04-22T07:44:26+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/recommendation-of-the-president-lamprene-clofazimine/ 2025-04-22T07:57:12+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/publication-awa-13/ 2025-04-22T08:04:36+00:00 https://www.aotm.gov.pl/en/aktualnosci/najnowsze/status-of-work-in-april-3/ 2025-04-22T08:07:58+00:00